You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 1
  • 5PSQ-112 Relationship between effectiveness and immune-mediated toxicity of immune check-point inhibitors in advanced non-small-cell lung cancer

Article info

Article menu

Download PDFPDF

Late breaking abstracts
5PSQ-112 Relationship between effectiveness and immune-mediated toxicity of immune check-point inhibitors in advanced non-small-cell lung cancer
Free

Authors

Citation

Miron Elorriaga G, Viseda Torrellas Y, Palacios Filardo M, et al
5PSQ-112 Relationship between effectiveness and immune-mediated toxicity of immune check-point inhibitors in advanced non-small-cell lung cancer
European Journal of Hospital Pharmacy 2023;30:A220.

Publication history

  • First published May 2, 2023.
Online issue publication 
May 02, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.